Key result
Diastolic heart failure carries a mortality rate approaching 15% per year in patients older than 65 years, with no improvement in prognosis over the past 20 years despite advances in diagnosis.
L eft ventricular (LV) diastolic dysfunction, as occurs in patients with hypertension, diabetes mellitus, and/or aging, carries a substantial risk of the subsequent development of heart failure and reduced survival, even when it is asymptomatic or "preclinical."[1][2][3][4] Diastolic dysfunction is defined as functional abnormalities that exist during LV relaxation and filling.When such abnormalities cause or contribute to the clinical syndrome of heart failure with a normal LV ejection fraction, it is appropriate to describe the condition as diastolic heart failure.This diagnosis carries a mortality rate that is similar to that seen in systolic failure, approaching 15% per year in patients older than 65 years.5,6 Over the past 20 years, the survival of patients with systolic heart failure has improved, whereas the prognosis of diastolic heart failure has not changed.5 Diagnostic echocardiographic and Doppler techniques have improved, 7 and criteria for the diagnosis of diastolic heart failure have been developed, 8,9 but the evolution of therapeutic strategies has not kept pace with this growing public health problem.Improved therapy will depend on basic research directed at mechanisms of disease, coupled with clinical investigations directed at diagnosis and therapy.
No takes yet. Share an insight, caveat, or question.
Gaasch et al. (2007) conducted a review in Left ventricular diastolic dysfunction and diastolic heart failure. Diastolic heart failure carries a mortality rate approaching 15% per year in patients older than 65 years, with no improvement in prognosis over the past 20 years despite advances in diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: